Skip to main content
Premium Trial:

Request an Annual Quote

J&J Expands In Silico Hematology Research Project with Entelos

NEW YORK, July 7 (GenomeWeb News) - Entelos said yesterday that it has expanded a hematology research collaboration with Johnson & Johnson Pharmaceutical Research & Development that began a year and a half ago.

 

In the expanded program, Entelos will use its PhysioLab biosimulation technology to study the effect of anti-anemia therapy on patients with different types of anemia. Entelos said it will also use its platform to "explore the impact of patient variability, and provide guidance on optimization of anemia clinical trials." 

 

Entelos and J&JPRD began co-developing developing the Hematopoiesis PhysioLab in January 2004.

 

Financial terms for the expanded agreement were not provided.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.